Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03460522
Title Inotuzumab Ozogamicin and Conventional Chemotherapy In Patients Aged 56 Years and Older With ALL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Nicola Goekbuget
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU


No variant requirements are available.